03.05.2019| | 2 Comments
information for STRATTERA. STRATTERA® (atomoxetine) CAPSULES for Oral Use. Initial U.S. Approval: WARNING: SUICIDAL IDEATION IN CHILDREN . STRATTERA was administered as a single dose in the early morning and titrated on a weight-adjusted basis according to clinical response, up to a maximum. After a 30‐day titration period, dosing patterns of atomoxetine monotherapy . Based on atomoxetine daily dose (after allowing for titration during the first .. Suboptimal dosing of Strattera (atomoxetine) for ADHD patients. None progressed to liver failure. Anaphylaxis, sgrattera, rash, and urticaria have been reported in patients taking atomoxetine. Limited data from case reports indicate that dyskinesias, tachycardia, elevated blood pressure, anorexia, insomnia, tremor, and hallucinations can occur click use of atomoxetine with other psychotropic agents. Stimulant medications, including amphetamine and methylphenidate, are most commonly used to treat ADHD. DSM-5 Task Force. Phenelzine: Severe The use of selective norepinephrine reuptake inhibitors with monoamine oxidase inhibitors is contraindicated. Chlorpheniramine; Hydrocodone; Phenylephrine: Moderate Due to strattera titration potential for additive increases in blood pressure and heart rate, atomoxetine should be used cautiously with vasopressors such as phenylephrine. Telavancin: Major QT prolongation has occurred during therapeutic xtrattera of atomoxetine titrahion following overdose. Although citalopram is a weak inhibitor of 2D6, the potential for an interaction exists.